School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Zhengye Biotechnology Holding Ltd ZYBT

Healthcare · Drug Manufacturers - Specialty & Generic

$1.73last close 2026-10-09 · market cap $81.99M · delayed data

Trailing returns

1M+10.19%
3M+124.09%
6M+74.75%
1Y-36.40%

Basis: Adjusted daily closes.

What it does

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine.

Open ZYBT in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies